Welcome, Friend!

It looks like you're new here. If you want to get involved, click one of these buttons!


Quick Start Forum Video Tutorial

Protect anonymity
We strongly suggest that members do not include their email addresses. Once that is published , your email address is available to anyone on the internet , including hackers.

All discussions and comments that contain an external URL will be automatically moved to the spam queue. No external URL pointing to a medical web site is permitted. Forum rules also indicate that you need prior moderator approval. If you are going to post an external URL, contact one of the moderators to get their approval.
There are no medical professionals on this forum side of the site. Therefore, no one is capable or permitted to provide any type of medical advice.
This includes any analysis, interpretation, or advice based on any diagnostic test

The main site has all the formal medical articles and videos for you to research on.

Oxycodone being discontinued?

AnonymousUserAAnonymousUser Posts: 49,512
edited 06/11/2012 - 7:23 AM in Pain Medications
I've been taking Oxycodone 80mg, 4 tabs daily for over 5 years and it has worked exceptionally well for me. I recently attempted to switch over to Methadone 10mg/day but side effects made me feel like I wanted to jump off the highest bridge I could find. I'm on Medicare with a supplemental policy through AARP and have paid only $7.00 per month for this generic form of Oxycontin. Now I understand that the manufacturers of generic Oxycodone intend to cease making this medication. Oxycontin will cost me over $600.00 per month. How can a drug manufacturer (the one making Oxycontin) force another manufacturer to stop making the generic form of the only pain reliever that works for me without causing me to consider suicide? :W This is just one more incidence of how far our drug companies have been allowed to go to control our lives and needs. Our only hope of controlling the health system in this country is to elect an administration which will make it a priority to fix this broken system. If you care about your present and future health as well as the health system your children will inherit, please cast your vote this November for ABC and XYZ

Edited by Ron DiLauro, Spine-Health Administrator 09/09/08 to remove political candidates names


  • I can't imagine any company discontinuing the manufacture of oxycodone, besides that, aren't there numerous companies that manufacture this med? And, what does ABC have to do with anything???

    Edit by Ron DiLauro, Spine-Health Administrator, 09/09/08 to remove political names

  • 1 post and starting a political debate, no thanks.
  • advertisement
  • I understand you are frustrated but don't take it out on the other poster. She is correct both ABC and XYZ have problems with Pharmaceutical companies.

    Oxy is off patent which means any company make it. It would just take a look and see what is happening. I just got my script filled today (90 pills..4mg) and it was $10. Also you may want to think about 80mg is a really high does and after five years of any medicine (especially a narcotic) you are going to have to wean yourself off or have really bad side effects.

    I wish you luck..but i don't think you should have any problem getting this product.


    Edit by Ron DiLauro, Spine-Health Administrator, 09/09/08 to remove political names
  • PART 1:

    IMPAX acknowledges validity, enforceability and infringement of Purdue Pharma’s OxyContin patents

    Stamford, CT – April 2, 2007 – Purdue Pharma L.P. of Stamford, Connecticut and IMPAX Laboratories, Inc. of Hayward, California have agreed to end their lawsuit concerning certain Purdue Pharma patents on OxyContin® (oxycodone HCl controlled-release) Tablets. Under the terms of the settlement agreement, IMPAX Laboratories acknowledges that Purdue Pharma’s OxyContin patents are valid, enforceable and infringed by IMPAX’s extended-release oxycodone products and Purdue agrees it will not pursue damages against IMPAX for past infringement. Purdue also will grant a license to permit IMPAX (through its marketing partner, DAVA Pharmaceuticals) to keep its extended-release oxycodone products on the market through June 14, 2007, with rights to resume distribution in the future of a limited amount of product for a limited period of time.

    PART 2:

    Purdue Pharma L.P. Announces Resolution of OxyContin® Patent Lawsuit with Mallinckrodt Inc.

    Mallinckrodt acknowledges validity of Purdue patents; Purdue licenses limited sales of some generic oxycodone strengths

    Stamford, CT – September 2, 2008 – Purdue Pharma L.P. of Stamford, Connecticut and Mallinckrodt Inc. of Hazelwood, Missouri have agreed to end the OxyContin® (oxycodone HCl controlled-release) Tablets patent infringement lawsuit between them in the United States District Court for the Southern District of New York.

    According to the agreement, Mallinckrodt acknowledges the validity and enforceability of Purdue's patents and admits that marketing generic versions of OxyContin under its Abbreviated New Drug Application (ANDA) without a license from Purdue would infringe these patents. In exchange, Purdue has agreed to grant Mallinckrodt a royalty-bearing license, ending in 2009, to sell limited quantities of generic versions of 10 mg, 20 mg, 40 mg, and 80 mg extended-release oxycodone tablets.

    In the most recent decision in the litigation which Purdue and Mallinckrodt have now settled, the United States District Court for the Southern District of New York rejected claims that the Purdue patents were unenforceable because of Purdue's alleged inequitable conduct in obtaining them. In an Opinion and Order dated January 7, 2008, the Court stated, "There is no evidence of deceptive intent with respect to Purdue’s failure to disclose prior controlled-release formulations or its failure to disclose [a Purdue scientist's] affiliations, both of which were made in good faith."

    "We are pleased to resolve the dispute with Mallinckrodt in a manner that respects our inventions," said John H. Stewart, President of Purdue Pharma, in announcing the end of the lawsuit. "We will continue to defend our inventions against infringers."

  • Well i sure hope they don't pull the plug on it alot of angry patients will ensue
  • advertisement
  • dilaurodilauro ConnecticutPosts: 12,807
    Lets not bring the presidential candidates into this post.
    It has no bearing on the subject at hand.
    Ron DiLauro Veritas-Health Forums Manager
    I am not a medical professional. I comment on personal experiences 
  • Ron~*

    Could you please modify the OP to remove the specific candidates he named? I, personally, find anyone endorsing a specific candidate or party on a chronic pain message board offensive. I appreciate that you put a stop to any potential discussion, but I feel that with that endorsement being left in the OP it just opens the doors for future posts to get into the political debate and surely, that's not something we want to get started here.

  • dilaurodilauro ConnecticutPosts: 12,807
    I should have deleted those names to start with. It is now done. Thanks again for your help in pointing that out
    Ron DiLauro Veritas-Health Forums Manager
    I am not a medical professional. I comment on personal experiences 
  • Thanks Ron!

    Like I've said before, anytime politics gets involved in anything it goes downhill...just trying to prevent that from happening to SH. I love her too much to do that to her! ;) Thanks for understanding my concern.
  • The ER of this med very expensive now. I dont have insurance, so I have to pay cash up front. Well, Im taking 20mg of Oxycodone 3x a day, and it cost around $40 for a month's worth. (my pharmacy doesnt carry 20mg tabs so I have to take four 5mg tabs) Well, my Dr wanted me to try something long lasting, so she had me try Oxycontin ER 20mg. For a month's worth, 56 tabs, $181.25!! I was told by pharmacist that they pulled their generic a couple weeks ago(something about a patent) so Im back on regular oxycodone as it is much cheaper. :)))
Sign In or Register to comment.